A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 9/12 (2006.01) A61K 9/72 (2006.01) A61K 47/48 (2006.01) A61P 11/06 (2006.01) A61P 37/08 (2006.01)
Patent
CA 2469082
The invention provides uses and methods for alleviating respiratory tract symptoms of allergy, asthma, and of viral, bacterial, fungal and parasitic infections by shifting inappropriate TH2 responses to TH1 responses by administering IL-13 receptor-targeted immunotoxins to the respiratory tract.
L'invention concerne des utilisations et des procédés destinés à atténuer des symptômes des voies respiratoires d'allergies, d'asthme et d'infections virales, bactériennes, fongiques et parasitiques par transfert de réponses TH2 inappropriées sur des réponses TH1 par administration d'immunotoxines ciblées sur le récepteur d'IL-3 aux voies respiratoires.
Hogaboam Cory M.
Jakubzick Claudia
Kunkel Steven L.
Puri Raj K.
Fetherstonhaugh & Co.
The Government Of The United States Of America
The Regents Of The University Of Michigan
LandOfFree
Chimeric molecule for the treatment of th2-like cytokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chimeric molecule for the treatment of th2-like cytokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric molecule for the treatment of th2-like cytokine... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1894344